ID | 52840 |
フルテキストURL | |
著者 |
Itoh, Mitsuya
Okayama Univ
Iwamoto, Takayuki
Okayama Univ
Nogami, Tomohiro
Okayama Univ
Motoki, Takayuki
Okayama Univ
publons
Niikura, Naoki
Tokai Univ
Hayashi, Naoki
St Lukes Int Hosp
Ohtani, Shoichiro
Hiroshima City Hosp
Higaki, Kenji
Hiroshima City Hosp
Symmans, W. Fraser
Univ Texas MD Anderson Canc Ctr
Pusztai, Lajos
Yale Univ
|
抄録 | We examined estrogen receptor (ER) mRNA expression and molecular subtypes in stage I-III breast cancers that are progesterone receptor (PR) positive but ER and HER2 negative by immunohistochemistry (IHC) or fluorescent in situ hybridization. The ER, PR, and HER2 status was determined by IHC as part of routine clinical assessment (N = 501). Gene expression profiling was done with the Affymetrix U133A gene chip. We compared expressions of ESR1 and MKI67 mRNA, distribution of molecular subtypes by the PAM50 classifier, the sensitivity to endocrine therapy index, and the DLDA30 chemotherapy response predictor signature among ER/PR-positive (n = 223), ER-positive/PR-negative (
|
キーワード | Estrogen receptor
Progesteron receptor
cDNA microarray
Breast cancer
Hormone therapy
|
備考 | The final publication is available at www.springerlink.com
|
発行日 | 2014-01
|
出版物タイトル |
Breast Cancer Research and Treatment
|
巻 | 143巻
|
号 | 2号
|
出版者 | Springer
|
開始ページ | 403
|
終了ページ | 409
|
ISSN | 0167-6806
|
NCID | AA10623184
|
資料タイプ |
学術雑誌論文
|
関連URL | http://ousar.lib.okayama-u.ac.jp/metadata/52821
|
言語 |
英語
|
著作権者 | © Springer Science+Business Media New York 2013
|
論文のバージョン | author
|
査読 |
有り
|
DOI | |
Web of Science KeyUT |